Francine Mesrati

Phase II trial of thalidomide in renal-cell carcinoma

Bernard Escudier, Nathalie Lassau, D. Couanet et al. · Annals of Oncology · 2002 · 110 citations

Urology, Phase Ii Trial, Genitourinary Cancer +3

Transcranial magnetic stimulation as an efficient treatment for psychogenic movement disorders

Béatrice Garcin, Emmanuel Roze, Francine Mesrati et al. · Journal of Neurology Neurosurgery & Psychiatry · 2013 · 73 citations

Impact of Transcranial Magnetic Stimulation on Functional Movement Disorders: Cortical Modulation or a Behavioral Effect?

Béatrice Garcin, Francine Mesrati, Cécile Hubsch et al. · Frontiers in Neurology · 2017 · 68 citations · Full text

Quality of life in functional movement disorders is as altered as in organic movement disorders

Thierry Gendre, Guilhem Carle, Francine Mesrati et al. · Journal of Psychosomatic Research · 2018 · 57 citations

Physical Activity, Kinesiology, Organic Movement Disorders +11

Somatosensory evoked potentials in the assessment of peripheral neuropathies: Commented results of a survey among French-speaking practitioners and recommendations for practice

Régine Morizot-Koutlidis, Nathalie André‐Obadia, J.-C. Antoine et al. · Neurophysiologie Clinique · 2015 · 10 citations

Stimulation Device, Peripheral Neuropathies, Neurophysiology +12